anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

197,281-197,340 of 319,975

filter-aware
13
The slide uses a pyramid structure to represent market size by patient population, with larger populations at the base.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
14
The slide uses a horizontal timeline structure with vertical segmentation by development stage. Patient numbers represent U.S. prevalence.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
16
The slide uses immunofluorescence microscopy to show structural damage and bar charts/traces to show functional respiratory recovery.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline/process on the right.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
18
The slide uses a series of four circular icons atop vertical color-coded columns to categorize medical indications by therapeutic area.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
19
The slide uses a hub-and-spoke style layout to show relationships between entities.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
20
The slide uses a dual-section layout separating commercial and clinical activities, with specific dates aligned to each milestone.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
21
The diagram features five core values: Co-Creation, Empowerment, Excellence, Humility, and Innovation.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
22
The chart uses a horizontal bar format to represent clinical trial progress from Preclinical to Commercial stages.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
01
Slide 1
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Why1 hit
02
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Why1 hit
03
The slide uses a four-column layout to summarize key corporate metrics and strategic focus areas.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · WhyLoop · Golden Circle1 hit
04
Slide 4 of a presentation, likely AstraZeneca.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
05
The slide uses bar charts to compare historical annual performance against 9M 2022 results.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
06
Uses a 2x2 grid layout to categorize capital allocation strategies.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Key MessagesLoop · Golden Circle1 hit
07
The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
08
The slide uses a matrix-like structure to compare past performance (9M 2022) with future focus (2023).AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
09
The slide highlights the strategic fit of the CinCor acquisition (baxdrostat) into the existing CVRM pipeline.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Thesis HeadlineLoop · Golden Circle1 hit
10
Includes clinical trial data visualization and deal structure details.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Thesis HeadlineLoop · Golden Circle1 hit
11
The slide uses a list-based layout to categorize clinical milestones.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Executive SummaryLoop · Golden Circle1 hit
12
The slide uses a combination of a timeline (H1/H2 2023) and a list for the pipeline. It includes a comprehensive legend for abbreviations at the bottom.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · RoadmapLoop · Golden Circle1 hit
13
The slide uses a combination of a horizontal bar chart for product durability and a vertical bar chart for revenue growth projections.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · RoadmapLoop · Golden Circle1 hit
14
The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
15
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · Closing Ask1 hit
16
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations 1 hit
17
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations 1 hit
18
AstraZeneca | Investor Conference Presentation Deck | 18 slidesAstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations 1 hit
01
Slide 1
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Includes a footer note specifying the date of the presentation as January 6th, 2023.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
04
Uses a hierarchical structure to break down the objective into three strategic pillars.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a timeline framework to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Roadmap1 hit
07
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
08
Uses a vertical timeline-style list to present the 'Huge Need for Development' metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate clinical progression and de-risking.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
11
The slide highlights the efficacy of RL-007 in cognitive endpoints during a Phase 2 study.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
12
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
13
The slide uses a feature-comparison matrix to highlight the competitive advantage of RL-007.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
14
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
18
The slide uses a split layout: a left-hand sidebar for product summary and a right-hand side for clinical data visualization.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
19
The slide uses a dark sidebar for product specs and a white main area for trial design and results.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
20
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
22
Includes a comparison chart of Etifoxine vs Lorazepam and a summary of Phase 1 trial design.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
The slide uses topographical brain maps to visualize EEG data changes across three cohorts (Placebo, Low Dose, High Dose).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
25
The chart displays pharmacodynamic data with error bars and significance markers (asterisks).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
26
The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
Uses a timeline-style visual to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
Includes a line chart showing HCQN subscale scores over time and a two-stage clinical trial design diagram.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Why Now1 hit
30
The slide uses a checkmark-based comparison matrix to highlight the unique value proposition of DMX-1002.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Why Now1 hit
31
ATAI | Investor Presentation Deck | 33 slidesATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
The slide uses a structured card-based layout to present four distinct business units.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit